We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$126M
AUM Growth
-$25.5M
Cap. Flow
-$24.9M
Cap. Flow %
-19.84%
Top 10 Hldgs %
47.53%
Holding
143
New
16
Increased
24
Reduced
11
Closed
74

Sector Composition

Rank Sector Weight
1 Healthcare 52.52%
2 Technology 21.51%
3 Consumer Discretionary 5.99%
4 Communication Services 3.46%
5 Financials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORN icon
101
Orion Group Holdings
ORN
$399M
-17,715
Closed -$97K
PBYI icon
102
Puma Biotechnology
PBYI
$446M
-11,972
Closed -$84K
PRPH
103
DELISTED
ProPhase Labs
PRPH
-2,026
Closed -$105K
RBBN icon
104
Ribbon Communications
RBBN
$365M
-10,011
Closed -$60K
RIGL icon
105
Rigel Pharmaceuticals
RIGL
$779M
-2,174
Closed -$79K
RLGT icon
106
Radiant Logistics
RLGT
$388M
-12,900
Closed -$82K
RNAC icon
107
Cartesian Therapeutics
RNAC
$259M
-742
Closed -$92K
RVMD icon
108
Revolution Medicines
RVMD
$43.5B
-23,637
Closed -$650K
SMIN icon
109
iShares MSCI India Small-Cap ETF
SMIN
$773M
-52,339
Closed -$3.15M
SMSI icon
110
Smith Micro Software
SMSI
$16M
-293
Closed -$57K
SND icon
111
Smart Sand
SND
$197M
-38,651
Closed -$95K
SPOK icon
112
Spok Holdings
SPOK
$239M
-15,666
Closed -$160K
STOK icon
113
Stoke Therapeutics
STOK
$2.04B
-47,594
Closed -$1.21M
SYRE icon
114
Spyre Therapeutics
SYRE
$8.91B
-525
Closed -$105K
TRUE
115
DELISTED
TrueCar
TRUE
-32,094
Closed -$134K
UTI icon
116
Universal Technical Institute
UTI
$1.45B
-14,793
Closed -$100K
VMD icon
117
Viemed Healthcare
VMD
$357M
-14,110
Closed -$78K
VRA icon
118
Vera Bradley
VRA
$96.1M
-10,541
Closed -$99K
VRCA icon
119
Verrica Pharmaceuticals
VRCA
$90.9M
-1,094
Closed -$137K
VSTM icon
120
Verastem
VSTM
$638M
-3,224
Closed -$119K
WSR
121
DELISTED
Whitestone REIT
WSR
-10,300
Closed -$100K
YUMC icon
122
Yum China
YUMC
$16.2B
-11,771
Closed -$684K
ZNTL icon
123
Zentalis Pharmaceuticals
ZNTL
$292M
-20,596
Closed -$1.37M
ARQ icon
124
Arq
ARQ
$96.6M
-11,495
Closed -$73K
LENZ
125
LENZ Therapeutics
LENZ
$165M
-8,701
Closed -$998K

Similar funds

HighVista Strategies's Q4 2021 Portfolio in Review

As of Q4 2021, HighVista Strategies held 143 positions worth $126M, down 17% from $151M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

HighVista Strategies withdrew a net $24.9M in Q4 2021, closing 74 positions and reducing 11 holdings. Its most notable exit was PPD, Inc. Common Stock, an estimated $3.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 44% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Coherent Inc worth $3.63M.

  • HighVista Strategies's largest Q4 2021 buy was Coherent Inc: 13,600 shares worth $3.63M.
  • HighVista Strategies added most to Gritstone bio, Inc. Common Stock in Q4 2021, an estimated $1.1M increase.
  • HighVista Strategies's biggest Q4 2021 reduction was Dell, cutting an estimated $19.3M.
  • HighVista Strategies fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $3.5M.
  • HighVista Strategies's ten largest holdings make up 48% of its $126M portfolio in Q4 2021.
  • HighVista Strategies opened 16 new positions and closed 74 in Q4 2021.
  • HighVista Strategies's portfolio value fell 17% quarter-over-quarter to $126M.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.